Case Report: single low-dose of denosumab as a trigger of MRONJ development in a patient with osteoporosis after bisphosphonate therapy. - Száraz D; Peřina V; Treglerová J; Macháček C; Zendulka O; Bořilová Linhartová P (Frontiers in oral health, 2024)